Sigma Planning’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Sigma Planning's TGTX Position: Q3 2026 in Review
Sigma Planning reduced its TG Therapeutics (TGTX) stake by 34% in Q3 2026, selling an estimated $281K and leaving 10,175 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #793.
Sigma Planning first reported a position in TGTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.27M in Q2 2025. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Sigma Planning held 10,175 shares of TG Therapeutics worth $568K as of Q3 2026.
- Sigma Planning sold 5,200 TG Therapeutics shares in Q3 2026, an estimated $281K.
- TG Therapeutics made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #793 holding.
- Sigma Planning first reported a position in TG Therapeutics in Q1 2025 and has held it in 4 quarters since.
- Sigma Planning's TG Therapeutics position peaked at $1.27M in Q2 2025.
- 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.